Atenolol
Product Images NDC 52959-463

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atenolol (NDC 52959-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atenololtabs-figure-01 (Atenololtabs Figure 01)

FDA Label Image

Atenololtabs-figure-02 (Atenololtabs Figure 02)

Atenololtabs-figure-02 (Atenololtabs Figure 02)
This is a description of a medication package containing Atentolol tablets, with a dosage of 25mg. It includes the lot number (ATL200RZ) and the expiration date (09/10), as well as the manufacturer (Ranbaxy P.) and origin country (India). The package also contains a pill ID and dosage information. Additionally, there is a comparison to another medication called Tenormin, which has a different manufacturer (Mfg. NDC: 63304-621-01). The text includes some illegible characters and appears to contain a mix of -generated content and input errors.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.